Friday, 6 September 2019

Ceisteanna (915, 932)

Jackie Cahill

Ceist:

915. Deputy Jackie Cahill asked the Minister for Health the reason Duodopa which is very beneficial to Parkinson's sufferers was recently withdrawn by the HSE; if he will engage with a charity (details supplied) on the matter and review the decision made by the HSE; and if he will make a statement on the matter. [35302/19]

Amharc ar fhreagra

Jan O'Sullivan

Ceist:

932. Deputy Jan O'Sullivan asked the Minister for Health his plans to ensure that patients who have Parkinson’s disease can continue to receive a medication (details supplied) which is no longer available to them despite having been provided to those who have an advanced stage of the condition; and if he will make a statement on the matter. [35373/19]

Amharc ar fhreagra

Freagraí scríofa (Ceist ar Health)

I propose to take Questions Nos. 915 and 932 together.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.